{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:53:55Z","timestamp":1790222035057,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013121","name":"Sydney West Translational Cancer Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1126955"],"award-info":[{"award-number":["1126955"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["TPG182165"],"award-info":[{"award-number":["TPG182165"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.mri.2025.110431","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:05:11Z","timestamp":1748801111000},"page":"110431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Longitudinal quantitative MRI in prostate cancer after radiation therapy with and without androgen deprivation therapy"],"prefix":"10.1016","volume":"122","author":[{"given":"Yu-Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirisha","family":"Tadimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niluja","family":"Thiruthaneeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarad","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mri.2025.110431_bb0005","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.juro.2015.06.100","article-title":"Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.mri.2025.110431_bb0010","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.21037\/tau.2019.08.21","article-title":"A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer","volume":"9","author":"Khoo","year":"2019","journal-title":"Transl Androl Urol"},{"issue":"38","key":"10.1016\/j.mri.2025.110431_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/EDBK_200319","article-title":"Management of biochemically recurrent prostate cancer: ensuring the right treatment of the right patient at the right time","volume":"38","author":"Spratt","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.mri.2025.110431_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-024-00883-3","article-title":"Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis","author":"Creta","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.mri.2025.110431_bb0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.euo.2024.09.015","article-title":"Prostate-specific membrane antigen positron emission tomography before reaching the phoenix criteria for biochemical recurrence of prostate cancer after radiotherapy: earlier detection of recurrences","volume":"8","author":"van Altena","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.mri.2025.110431_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28817-9","article-title":"Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer","volume":"8","author":"Pasquier","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.mri.2025.110431_bb0035","doi-asserted-by":"crossref","first-page":"W477","DOI":"10.2214\/AJR.09.3557","article-title":"Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T","volume":"194","author":"Song","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.mri.2025.110431_bb0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.diii.2019.06.003","article-title":"Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI)","volume":"100","author":"Wu","year":"2019","journal-title":"Diagn Interv Imaging"},{"issue":"18","key":"10.1016\/j.mri.2025.110431_bb0045","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.3390\/cancers14184475","article-title":"Longitudinal changes and predictive value of multiparametric MRI features for prostate cancer patients treated with MRI-guided lattice extreme ablative dose (LEAD) boost radiotherapy","volume":"14","author":"Algohary","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.mri.2025.110431_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2009.08.016","volume":"93","author":"Franiel","year":"2009","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.mri.2025.110431_bb0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2214\/AJR.10.6356","article-title":"Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy","volume":"197","author":"Low","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.mri.2025.110431_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109677","article-title":"The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients","volume":"184","author":"Onal","year":"2023","journal-title":"Radiother Oncol"},{"issue":"16","key":"10.1016\/j.mri.2025.110431_bb0065","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-17-3806","article-title":"Combined MR imaging of oxygen consumption and supply reveals tumor hypoxia and aggressiveness in prostate cancer patients","volume":"78","author":"Hompland","year":"2018","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.mri.2025.110431_bb0070","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2007.01.018","article-title":"Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations","volume":"68","author":"Hoskin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3026","key":"10.1016\/j.mri.2025.110431_bb0075","article-title":"Daily Intravoxel incoherent motion (IVIM) in prostate cancer patients during MR-guided radiotherapy-a multicenter study","volume":"11","author":"Kooreman","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.mri.2025.110431_bb0080","doi-asserted-by":"crossref","first-page":"W645","DOI":"10.2214\/AJR.13.12277","article-title":"Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer","volume":"203","author":"Kim","year":"2014","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"10.1016\/j.mri.2025.110431_bb0085","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00330-015-3688-1","article-title":"Prostate cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI","volume":"25","author":"Hotker","year":"2015","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.mri.2025.110431_bb0090","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mrm.23062","article-title":"DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study","volume":"67","author":"Barrett","year":"2012","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.1016\/j.mri.2025.110431_bb0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1148\/radiology.218.2.r01ja04365","article-title":"Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging","volume":"218","author":"Padhani","year":"2001","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.mri.2025.110431_bb0100","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.acra.2019.10.017","article-title":"Multiparametric MRI as a biomarker of response to neoadjuvant therapy for localized prostate Cancer-a pilot study","volume":"27","author":"Fennessy","year":"2020","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.mri.2025.110431_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2014.07.016","article-title":"Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T","volume":"113","author":"Decker","year":"2014","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.mri.2025.110431_bb0110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ijrobp.2011.06.2009","article-title":"Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer","volume":"83","author":"Park","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.mri.2025.110431_bb0115","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/jmri.21388","article-title":"ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy","volume":"27","author":"Takayama","year":"2008","journal-title":"J Magn Reson Imaging"},{"issue":"1043","key":"10.1016\/j.mri.2025.110431_bb0120","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140359","article-title":"Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer","volume":"87","author":"Liu","year":"2014","journal-title":"Br J Radiol"},{"issue":"12","key":"10.1016\/j.mri.2025.110431_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1756287218798748","article-title":"Changes in prostate apparent diffusion coefficient values during radiotherapy after neoadjuvant hormones","volume":"10","author":"McPartlin","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.mri.2025.110431_bb0130","series-title":"BiRT - Tumour Segmentation CNN Model for mpMRI Prostate","author":"Sun","year":"2023"},{"issue":"4","key":"10.1016\/j.mri.2025.110431_bb0135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.mri.2025.110431_bb0140","series-title":"Proceedings of the 9th Python in Science Conference, Austin, TX","doi-asserted-by":"crossref","DOI":"10.25080\/Majora-92bf1922-011","article-title":"Statsmodels: Econometric and statistical modeling with python","volume":"Vol. 57","author":"Seabold","year":"2010"},{"issue":"3","key":"10.1016\/j.mri.2025.110431_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.mri.2025.110431_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s10334-025-01231-9","article-title":"Anatomical zone and tissue type impacts the repeatability of quantitative MRI parameters and radiomic features for longitudinal monitoring of treatment response in the prostate","author":"Wang","year":"2025","journal-title":"MAGMA"},{"issue":"4","key":"10.1016\/j.mri.2025.110431_bb0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jmri.22838","article-title":"Tumor response assessments with diffusion and perfusion MRI","volume":"35","author":"Li","year":"2012","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.mri.2025.110431_bb0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1148\/radiol.2017161599","article-title":"Development of a combined MR fingerprinting and diffusion examination for prostate Cancer","volume":"283","author":"Yu","year":"2017","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.mri.2025.110431_bb0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/RLI.0000000000000569","article-title":"Targeted biopsy validation of peripheral zone prostate cancer characterization with magnetic resonance fingerprinting and diffusion mapping","volume":"54","author":"Panda","year":"2019","journal-title":"Investig Radiol"},{"issue":"1","key":"10.1016\/j.mri.2025.110431_bb0170","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/s41598-020-59942-z","article-title":"Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a modified look-locker inversion recovery sequence","volume":"10","author":"Baur","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.mri.2025.110431_bb0175","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s00330-020-07214-9","article-title":"T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology","volume":"31","author":"Shiradkar","year":"2021","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.mri.2025.110431_bb0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1464-410X.2006.06013.x","article-title":"Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer","volume":"97","author":"Murthy","year":"2006","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.mri.2025.110431_bb0185","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2018.11.007","article-title":"A nomogram for testosterone recovery after combined androgen deprivation and radiation therapy for prostate cancer","volume":"103","author":"Spiegel","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.mri.2025.110431_bb0190","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mp.16026","article-title":"Seq2Morph: a deep learning deformable image registration algorithm for longitudinal imaging studies and adaptive radiotherapy","volume":"50","author":"Lee","year":"2023","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.mri.2025.110431_bb0195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12894-022-01125-1","article-title":"Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients","volume":"22","author":"Cetin","year":"2022","journal-title":"BMC Urol"},{"issue":"4","key":"10.1016\/j.mri.2025.110431_bb0200","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/annonc\/mdp365","article-title":"Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy","volume":"21","author":"de Crevoisier","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mri.2025.110431_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2021.11.005","article-title":"Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: the Phoenix definition and beyond","volume":"166","author":"Ma","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.mri.2025.110431_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2019.04.003","article-title":"Early biochemical predictors of survival in intermediate and high-risk prostate cancer treated with radiation and androgen deprivation therapy","volume":"140","author":"Patel","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X25001158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X25001158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:18:17Z","timestamp":1755616697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X25001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"alternative-id":["S0730725X25001158"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2025.110431","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal quantitative MRI in prostate cancer after radiation therapy with and without androgen deprivation therapy","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mri.2025.110431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110431"}}